Incidence of COVID-19 in patients under chronic treatment with hydroxychloroquine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Incidence of COVID-19 in patients under chronic treatment with hydroxychloroquine

Published:2021-02 Issue:4 Volume:156 Page:166-171
ISSN:2387-0206
Container-title:Medicina Clínica (English Edition)
language:en
Short-container-title:Medicina Clínica (English Edition)

Author:

Tejada Cifuentes Francisco,Lloret Callejo Ángeles,Tirado Peláez María José,Rubio Pulido Olga,Ruiz-Morote Aragón Marta,Fernández Urrusuno Rocío,Muñoz Carreras María Isabel,Méndez Esteban María Isabel,Maestre Sánchez Victoria,García Bonilla Antonio,Paredero Dominguez José Manuel,Arroyo Pineda Virginia,Marco Tejón Esther,Romero Candel Gregorio,Fernández Marchante Ana Isabel,Marco del Rio José,Ortiz Martín Teresa,López Sánchez Piedad

Publisher

Elsevier BV

Subject

General Medicine

Reference22 articles.

1. Principles of ethical prescribing for self and others: hydroxychloroquine in the COVID-19 pandemic;Coombes;Aust Prescr,2020

2. Hydroxychloroquine and COVID-19: critiquing the impact of disease public profile on policy and clinical decision-making;Aquino;J Med Ethics,2020

3. Infectious diseases Society of America guidelines on the treatment and management of patients with COVID-19;Bhimraj;Clin Infect Dis,2020

4. Cortegiani A, Ingoglia G, Ippolito M, Giarratno A, Einav S. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. Available from: https://doi.org/10.1016/j.jcrc.2020.03.005.

5. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2);Yao;Clin Infect Dis,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP